Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-25-001617
Filing Date
2025-03-14
Accepted
2025-03-14 17:00:19
Documents
58
Period of Report
2025-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR DEC 2024 odyssey_i10q-013125.htm   iXBRL 10-Q 645705
2 CERTIFICATION odyssey_ex3101.htm EX-31.1 7782
3 CERTIFICATION odyssey_ex3102.htm EX-31.2 7753
4 CERTIFICATION odyssey_ex3201.htm EX-32.1 3714
5 CERTIFICATION odyssey_ex3202.htm EX-32.2 3665
  Complete submission text file 0001683168-25-001617.txt   4095145

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE odyy-20250131.xsd EX-101.SCH 31744
7 XBRL CALCULATION FILE odyy-20250131_cal.xml EX-101.CAL 40937
8 XBRL DEFINITION FILE odyy-20250131_def.xml EX-101.DEF 137445
9 XBRL LABEL FILE odyy-20250131_lab.xml EX-101.LAB 289559
10 XBRL PRESENTATION FILE odyy-20250131_pre.xml EX-101.PRE 249776
60 EXTRACTED XBRL INSTANCE DOCUMENT odyssey_i10q-013125_htm.xml XML 523482
Mailing Address 2300 WEST SAHARA AVENUE SUITE 800-#4012 LAS VEGAS NV 89102
Business Address 2300 WEST SAHARA AVENUE SUITE 800-#4012 LAS VEGAS NV 89102 702-780-6559
Odyssey Health, Inc. (Filer) CIK: 0001626644 (see all company filings)

EIN.: 471022125 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-56196 | Film No.: 25741063
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)